Anna-Karin Maltais, based in Sweden, is currently a Head of CMC at Biotech Research and Product Development, R and D, Global Rare Diseases at Chiesi Group, bringing experience from previous roles at Eurocine Vaccines Ab and Cyto Pulse Sciences, Inc.. Anna-Karin Maltais holds a 2002 - 2006 Ph.D @ Karolinska institutet, Sweden. With a robust skill set that includes Equity Research, Equities, Biopharmaceuticals, Molecular Biology, Biochemistry and more, Anna-Karin Maltais contributes valuable insights to the industry. Anna-Karin Maltais has 2 emails on RocketReach.